Showing results (271-280 of 413) with videos related to

Sort By:
Pageof 42
Prostate Cancer and Prostatic Diseases|November 24, 2021
Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trialDharam Kaushik, Pankil K Shah, Neelam Mukherjee, et al.
Nutrition and Cancer|January 29, 2021
Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention TrialSusan Chadid, Xiaoling Song, Jeannette M Schenk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2014
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialAlan R Kristal, Cathee Till, Xiaoling Song, et al.
European Urology Oncology|November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216Umang Swami, Yeonjung Jo, Arshit Narang, et al.
Urology|March 6, 2012
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109Ryan K Berglund, Catherine M Tangen, Isaac J Powell, et al.
The Prostate|January 3, 2013
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancerChun-Liang Chen, Devalingam Mahalingam, Pawel Osmulski, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2013
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trialMarian L Neuhouser, Elizabeth A Platz, Cathee Till, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Urology|May 15, 2014
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention TrialWilliam D Figg, Cindy H Chau, Douglas K Price, et al.
Pageof 42